Results of univariate and multivariate logistic regression analyses
| Parameter . | Odds ratio . | Univariate analysis . | P value . |
|---|---|---|---|
| 95% Confidence interval . | |||
| Age, y | 1.02 | 0.97-1.07 | .814 |
| Sex (female vs male) | 2.06 | 0.76-6.00 | .231 |
| Weight, kg | 1.02 | 0.99-1.05 | .230 |
| Prior exposure to TCRT (no vs yes) | 6.80 | 2.41-20.80 | .002 |
| High-risk cytogenetic features (no vs yes) | 4.63 | 1.67-14.03 | .011 |
| Elevated M-spike (no vs yes) | 1.74 | 0.21-36.30 | .851 |
| Elevated LDH (no vs yes) | 0.56 | 0.18-1.63 | .411 |
| Extramedullary disease (no vs yes) | 0.62 | 0.19-1.80 | .504 |
| Number of prior lines of therapy | 1.24 | 1.04-1.51 | .041 |
| Parameter . | Odds ratio . | Univariate analysis . | P value . |
|---|---|---|---|
| 95% Confidence interval . | |||
| Age, y | 1.02 | 0.97-1.07 | .814 |
| Sex (female vs male) | 2.06 | 0.76-6.00 | .231 |
| Weight, kg | 1.02 | 0.99-1.05 | .230 |
| Prior exposure to TCRT (no vs yes) | 6.80 | 2.41-20.80 | .002 |
| High-risk cytogenetic features (no vs yes) | 4.63 | 1.67-14.03 | .011 |
| Elevated M-spike (no vs yes) | 1.74 | 0.21-36.30 | .851 |
| Elevated LDH (no vs yes) | 0.56 | 0.18-1.63 | .411 |
| Extramedullary disease (no vs yes) | 0.62 | 0.19-1.80 | .504 |
| Number of prior lines of therapy | 1.24 | 1.04-1.51 | .041 |
| . | Odd ratio . | Multivariate analysis . | P value . |
|---|---|---|---|
| 95% Confidence interval . | |||
| Prior exposure to TCRT (no vs yes) | 4.44 | 1.40-14.90 | |
| High-risk cytogenetic features (no vs yes) | 3.13 | 1.01-10.20 | .0002 |
| Number of prior lines of therapy | 1.09 | 0.89-1.35 |
| . | Odd ratio . | Multivariate analysis . | P value . |
|---|---|---|---|
| 95% Confidence interval . | |||
| Prior exposure to TCRT (no vs yes) | 4.44 | 1.40-14.90 | |
| High-risk cytogenetic features (no vs yes) | 3.13 | 1.01-10.20 | .0002 |
| Number of prior lines of therapy | 1.09 | 0.89-1.35 |
TCRT, T-cell redirection therapy.